CABERGOLINE
CABERGOLINE
Manufacturer: SOLA Pharmaceuticals, LLC
Indicated for:
FDA-Approved Indications (1)
indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas
Population: all ages
Indications & Usage
INDICATIONS AND USAGE Cabergoline Tablets, USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.
💙 Support Programs
View all →Cabergoline
Pfizer
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.